Cargando…
Prevalence of depression among Iranian patients with myasthenia gravis during 2017-2018
Background: Myasthenia gravis (MG) is a chronic neuromuscular disease, which physically and mentally affects the patient’s life, with depression being one of the most important psychological complications in these patients. This study aims to investigate the prevalence of depression and its associat...
Autores principales: | Amani, Kiana, Sarraf, Payam, Abkhoo, Alireza, Tafakhori, Abbas, Fatehi, Farzad, Bitarafan, Sama, Agah, Elmira, Shariat, Mamak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236433/ http://dx.doi.org/10.18502/cjn.v19i4.5542 |
Ejemplares similares
-
Nutritional Aspects of Treatment in Epileptic Patients
por: SOLTANI, Danesh, et al.
Publicado: (2016) -
A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A single-center experience
por: Ziaadini, Bentolhoda, et al.
Publicado: (2022) -
Stability monitoring of patients with myasthenia gravis using a mobile-based application
por: Alaei Tafti, Emad, et al.
Publicado: (2023) -
Electrophysiological studies in patients with seropositive/seronegative myasthenia gravis
por: Vahabi, Zahra, et al.
Publicado: (2021) -
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar
por: Fatehi, Farzad, et al.
Publicado: (2021)